• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐抗菌药物的宋内志贺菌:儿童抗菌治疗选择有限及体外阿奇霉素敏感性解读的挑战

Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility.

作者信息

Jain Sanjay K, Gupta Amita, Glanz Brian, Dick James, Siberry George K

机构信息

Division of Pediatric Infectious Diseases, Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA.

出版信息

Pediatr Infect Dis J. 2005 Jun;24(6):494-7. doi: 10.1097/01.inf.0000164707.13624.a7.

DOI:10.1097/01.inf.0000164707.13624.a7
PMID:15933557
Abstract

BACKGROUND

Antimicrobial-resistant Shigella sonnei is a growing problem in the United States and poses treatment challenges particularly among children. Azithromycin is recommended as an alternative oral agent for shigellosis.

METHODS

All isolates of Shigella submitted to Johns Hopkins clinical laboratory during the outbreak year (2002) were compared with a historical comparison group (1996-2000). Isolates were considered multiresistant if they were resistant to ampicillin and trimethoprim-sulfamethoxazole (TS). Selected outbreak and reference isolates were tested for azithromycin susceptibility by E-test, disk diffusion and broth dilution methods.

RESULTS

Between 1996-2000, among the 111 isolates submitted, 63% were from pediatric patients; 63% of isolates were resistant to ampicillin and 12% to TS. In 2002, among the 205 isolates submitted, 82% were from pediatric patients; 91% isolates were resistant to ampicillin and 67% to TS. The proportion of multiresistant isolates increased from 6% in 1996 to 65% in 2002 (P < 0.05). Azithromycin susceptibility by E-test and disk diffusion demonstrated 2 zones of inhibition for S. sonnei. Interpretation using the inner zone resulted in higher MICs (minimal inhibitory concentration) compared with the outer zones by E-test (P < 0.0001) and disk diffusion (P < 0.0001).

CONCLUSIONS

With increasing interest in using azithromycin for shigellosis, clinical laboratories should be aware of the interpretation difficulty caused by the dual-zone phenomenon seen with E-test and disk diffusion methods for S. sonnei.

摘要

背景

在美国,耐抗生素的宋内志贺菌问题日益严重,尤其给儿童治疗带来挑战。阿奇霉素被推荐作为志贺菌病的替代口服药物。

方法

将疫情爆发年(2002年)提交至约翰霍普金斯临床实验室的所有宋内志贺菌分离株与历史对照组(1996 - 2000年)进行比较。如果分离株对氨苄西林和甲氧苄啶 - 磺胺甲恶唑(TS)耐药,则被视为多重耐药。通过E试验、纸片扩散法和肉汤稀释法对选定的疫情爆发和参考分离株进行阿奇霉素敏感性测试。

结果

1996 - 2000年期间,提交的111株分离株中,63%来自儿科患者;63%的分离株对氨苄西林耐药,12%对TS耐药。2002年,提交的205株分离株中,82%来自儿科患者;91%的分离株对氨苄西林耐药,67%对TS耐药。多重耐药分离株的比例从1996年的6%增加到2002年的65%(P < 0.05)。通过E试验和纸片扩散法检测阿奇霉素敏感性时,宋内志贺菌出现了两个抑菌圈。与E试验(P < 0.0001)和纸片扩散法(P < 0.0001)的外圈相比,使用内圈进行解读时,最低抑菌浓度(MIC)更高。

结论

随着对使用阿奇霉素治疗志贺菌病的兴趣增加,临床实验室应意识到E试验和纸片扩散法对宋内志贺菌出现的双圈现象所导致的解读困难。

相似文献

1
Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility.耐抗菌药物的宋内志贺菌:儿童抗菌治疗选择有限及体外阿奇霉素敏感性解读的挑战
Pediatr Infect Dis J. 2005 Jun;24(6):494-7. doi: 10.1097/01.inf.0000164707.13624.a7.
2
Transmission risk factors and treatment of pediatric shigellosis during a large daycare center-associated outbreak of multidrug resistant Shigella sonnei: implications for the management of shigellosis outbreaks among children.儿童保健中心相关多重耐药福氏志贺菌感染爆发期间小儿志贺菌病的传播危险因素和治疗:对儿童志贺菌病爆发管理的启示。
Pediatr Infect Dis J. 2009 Nov;28(11):976-80. doi: 10.1097/INF.0b013e3181a76eab.
3
Reduced azithromycin susceptibility in Shigella sonnei, United States.宋内志贺菌对阿奇霉素的敏感性降低,美国。
Microb Drug Resist. 2010 Dec;16(4):245-8. doi: 10.1089/mdr.2010.0028. Epub 2010 Jul 12.
4
Decreased Susceptibility to Azithromycin Among Clinical Shigella Isolates from China.中国临床分离志贺菌对阿奇霉素的敏感性降低。
Microb Drug Resist. 2017 Jul;23(5):596-601. doi: 10.1089/mdr.2016.0134. Epub 2016 Nov 14.
5
Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community-Vermont, 2018.阿奇霉素和环丙沙星治疗退伍军人社区中多重耐药福氏志贺菌感染爆发的效果-佛蒙特州,2018 年。
Clin Infect Dis. 2022 Feb 11;74(3):455-460. doi: 10.1093/cid/ciab450.
6
Surveillance of antimicrobial susceptibility patterns among Shigella species isolated in China during the 7-year period of 2005-2011.2005-2011 年中国 7 年间志贺菌属分离株的抗菌药物敏感性监测。
Ann Lab Med. 2013 Mar;33(2):111-5. doi: 10.3343/alm.2013.33.2.111. Epub 2013 Feb 21.
7
Evaluation of Shigella Species Azithromycin CLSI Epidemiological Cutoff Values and Macrolide Resistance Genes.评价志贺菌属种阿奇霉素 CLSI 流行 cutoff 值和大环内酯类耐药基因。
J Clin Microbiol. 2019 Mar 28;57(4). doi: 10.1128/JCM.01422-18. Print 2019 Apr.
8
Antibiotic resistance and molecular characterization of shigella isolates recovered from children aged less than 5 years in Manhiça, Southern Mozambique.莫桑比克马希埃拉地区 5 岁以下儿童感染志贺菌的耐药性及分子特征研究
Int J Antimicrob Agents. 2018 Jun;51(6):881-887. doi: 10.1016/j.ijantimicag.2018.02.005. Epub 2018 Feb 12.
9
Clinical Outcomes of Drug-resistant Shigellosis Treated With Azithromycin in Bangladesh.孟加拉国阿奇霉素治疗耐药志贺菌病的临床结局。
Clin Infect Dis. 2021 May 18;72(10):1793-1798. doi: 10.1093/cid/ciaa363.
10
Emergence of antimicrobial-resistant shigellosis in Oregon.俄勒冈州出现耐抗菌药物的志贺氏菌病。
Clin Infect Dis. 2000 Mar;30(3):515-9. doi: 10.1086/313715.

引用本文的文献

1
Decreased Susceptibility of Isolates to Azithromycin in Children in Tehran, Iran.伊朗德黑兰儿童分离株对阿奇霉素的敏感性降低
Can J Infect Dis Med Microbiol. 2022 Mar 27;2022:4503964. doi: 10.1155/2022/4503964. eCollection 2022.
2
Laboratory-based surveillance of Shigella spp. from human clinical cases in Colombia, 1997-2018.哥伦比亚 1997-2018 年基于实验室的人类临床病例中志贺氏菌属的监测。
Biomedica. 2021 Mar 19;41(1):65-78. doi: 10.7705/biomedica.5113.
3
Evaluation of Shigella Species Azithromycin CLSI Epidemiological Cutoff Values and Macrolide Resistance Genes.
评价志贺菌属种阿奇霉素 CLSI 流行 cutoff 值和大环内酯类耐药基因。
J Clin Microbiol. 2019 Mar 28;57(4). doi: 10.1128/JCM.01422-18. Print 2019 Apr.
4
Closed Genome and Comparative Phylogenetic Analysis of the Clinical Multidrug Resistant Shigella sonnei Strain 866.临床多重耐药宋内志贺菌 866 株的闭合基因组与系统进化比较分析
Genome Biol Evol. 2018 Sep 1;10(9):2241-2247. doi: 10.1093/gbe/evy168.
5
Azithromycin Resistance in Shigella spp. in Southeast Asia.志贺菌属中阿奇霉素耐药性在东南亚地区的流行情况。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.01748-17. Print 2018 Apr.
6
Comparative analysis of antimicrobial resistance in enterotoxigenic Escherichia coli isolates from two paediatric cohort studies in Lima, Peru.秘鲁利马两项儿科队列研究中分离出的产肠毒素大肠杆菌的抗菌药物耐药性比较分析。
Trans R Soc Trop Med Hyg. 2015 Aug;109(8):493-502. doi: 10.1093/trstmh/trv054.
7
Isolation and antibiotic susceptibility of Shigella species from stool samples among hospitalized children in Abadan, Iran.伊朗阿巴丹住院儿童粪便样本中志贺菌属的分离及抗生素敏感性分析
Gastroenterol Hepatol Bed Bench. 2014 Fall;7(4):218-23.
8
Options for treating resistant Shigella species infections in children.儿童耐药志贺菌属感染的治疗选择。
J Pediatr Pharmacol Ther. 2008 Jan;13(1):29-43. doi: 10.5863/1551-6776-13.1.29.
9
Genotypes and antimicrobial profiles of Shigella sonnei isolates from diarrheal patients circulating in Beijing between 2002 and 2007.2002 年至 2007 年间北京地区腹泻患者中流行的宋内志贺菌分离株的基因型和抗菌谱。
Diagn Microbiol Infect Dis. 2012 Oct;74(2):166-70. doi: 10.1016/j.diagmicrobio.2012.06.026. Epub 2012 Jul 31.
10
A unified approach to molecular epidemiology investigations: tools and patterns in California as a case study for endemic shigellosis.一种统一的分子流行病学研究方法:以加利福尼亚州为地方性志贺菌病案例研究的工具和模式
BMC Infect Dis. 2009 Nov 24;9:184. doi: 10.1186/1471-2334-9-184.